Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PharmacoEconomics - open

Showing results (1-10 of 651) with videos related to

Pageof 66
Sort By:
Pharmacoeconomics - Open|December 4, 2021
Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016-2018Rose J Geurten, Jeroen N Struijs, Arianne M J Elissen, et al.
Pharmacoeconomics - Open|February 24, 2019
Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) AmyloidosisKristen L McCausland, Avery A Rizio, Michelle K White, et al.
Pharmacoeconomics - Open|August 29, 2019
Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart ReviewJorge Arturo Alatorre, Saúl Campos-Gómez, Emmanuel De la Mora, et al.
Pharmacoeconomics - Open|September 29, 2019
Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast CountsD Coyle, Pierre J A Villeneuve
Pharmacoeconomics - Open|October 7, 2019
Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete ResectionRachael Batteson, Rose Hart, Matthew Hemstock, et al.
Pharmacoeconomics - Open|January 22, 2021
An Exploration on Attribute Non-attendance Using Discrete Choice Experiment Data from the Irish EQ-5D-5L National Valuation StudyEdel Doherty, Anna Hobbins, David G T Whitehurst, et al.
Pharmacoeconomics - Open|January 19, 2021
Economic Analysis of Transforaminal Lumbar Interbody Fusion Surgery Utilizing a Curved Bone Removal DeviceJohn H Peloza, Michael A Millgram, Erel Jacobian, et al.
Pharmacoeconomics - Open|January 20, 2021
A Review of Cost-Effectiveness Studies of Pembrolizumab Regimens for the Treatment of Advanced Non-small Cell Lung CancerNan Qiao, Ralph Insinga, Gilberto de Lima Lopes Junior, et al.
Pharmacoeconomics - Open|January 8, 2022
Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled TrialBettina Wulff Risør, Ditte Hoffmann Frydendal, Marie Konge Villemoes, et al.
Pharmacoeconomics - Open|October 19, 2018
Strimvelis<sup>®</sup> for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology EvaluationEmily South, Edward Cox, Nick Meader, et al.
Pageof 66

Showing results (1-10 of 651) with videos related to

Sort By:
Pageof 66
Pharmacoeconomics - Open|December 4, 2021
Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016-2018Rose J Geurten, Jeroen N Struijs, Arianne M J Elissen, et al.
Pharmacoeconomics - Open|February 24, 2019
Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) AmyloidosisKristen L McCausland, Avery A Rizio, Michelle K White, et al.
Pharmacoeconomics - Open|August 29, 2019
Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart ReviewJorge Arturo Alatorre, Saúl Campos-Gómez, Emmanuel De la Mora, et al.
Pharmacoeconomics - Open|September 29, 2019
Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast CountsD Coyle, Pierre J A Villeneuve
Pharmacoeconomics - Open|October 7, 2019
Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete ResectionRachael Batteson, Rose Hart, Matthew Hemstock, et al.
Pharmacoeconomics - Open|January 22, 2021
An Exploration on Attribute Non-attendance Using Discrete Choice Experiment Data from the Irish EQ-5D-5L National Valuation StudyEdel Doherty, Anna Hobbins, David G T Whitehurst, et al.
Pharmacoeconomics - Open|January 19, 2021
Economic Analysis of Transforaminal Lumbar Interbody Fusion Surgery Utilizing a Curved Bone Removal DeviceJohn H Peloza, Michael A Millgram, Erel Jacobian, et al.
Pharmacoeconomics - Open|January 20, 2021
A Review of Cost-Effectiveness Studies of Pembrolizumab Regimens for the Treatment of Advanced Non-small Cell Lung CancerNan Qiao, Ralph Insinga, Gilberto de Lima Lopes Junior, et al.
Pharmacoeconomics - Open|January 8, 2022
Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled TrialBettina Wulff Risør, Ditte Hoffmann Frydendal, Marie Konge Villemoes, et al.
Pharmacoeconomics - Open|October 19, 2018
Strimvelis<sup>®</sup> for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology EvaluationEmily South, Edward Cox, Nick Meader, et al.
Pageof 66